封面
市场调查报告书
商品编码
1796885

女性科技市场-全球产业规模、份额、趋势、机会和预测(按产品、应用、最终用途、地区和竞争细分,2020-2030 年)

Female Technology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End-use, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球女性科技 (Femtech) 市场价值为 393.4 亿美元,预计到 2030 年将达到 978.8 亿美元,预测期内的复合年增长率为 16.41%。受数位素养率、网路连线、智慧型手机普及率和数位医疗基础设施不断提高的推动,全球女性科技 (Femtech) 市场正在经历显着成长。此外,健身追踪器和智慧手錶等智慧穿戴装置的日益普及预计将促进女性科技 (Femtech) 市场的成长。此外,已开发国家和发展中国家越来越多地采用数位解决方案,加上技术的进步,预计将在预测期内推动市场成长。 FemTech(女性科技)是一项改善女性健康与福祉的科技。这个术语经常用于指旨在增强或支持女性健康的计划、服务、产品、软体、硬体、维生素、补充剂、远距医疗、穿戴式装置、数位平台和消费品,包括但不限于那些认定为顺性别女性和性别或性少数群体的女性。

市场概览
预测期 2026-2030
2024年市场规模 393.4亿美元
2030年市场规模 978.8亿美元
2025-2030 年复合年增长率 16.41%
成长最快的领域 怀孕和护理
最大的市场 北美洲

女性科技公司专注于开发满足女性独特医疗保健和健康需求的科技产品和服务。随着人们对女性健康和福祉重要性的认识不断提高,对女性科技产品的需求也日益增长。此外,由于潜在的丰厚回报,投资人对女性科技公司的投资兴趣也日益浓厚。例如,根据PitchBook的数据,2020年女性科技公司获得了超过8.2亿美元的融资。因此,市场中不断涌现的投资机会预计将支持女性科技市场的成长。

关键市场驱动因素

女性健康问题日益普遍

主要市场挑战

医学研究与设计中的性别偏见

主要市场趋势

生育和生殖健康解决方案的扩展

目录

第一章:服务概述

  • 市场定义
  • 市场范围
    • 覆盖市场
    • 考虑学习的年限
    • 主要市场区隔

第二章:研究方法

第三章:执行摘要

第四章:顾客之声

第五章:全球女性科技(Femtech)市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按产品(行动应用程式、连接装置、服务、其他)
    • 依应用(生殖健康、一般健康、怀孕和护理、骨盆和子宫护理)
    • 依最终用途(个人、生育诊所、医院、研究机构、诊断中心)
    • 按地区
    • 按公司分类(2024)
  • 产品图
    • 按产品
    • 按应用
    • 按最终用途
    • 按地区

第六章:欧洲女性科技(Femtech)市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 法国
    • 英国
    • 义大利
    • 德国
    • 西班牙

第七章:北美女性科技(Femtech)市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 美国
    • 墨西哥
    • 加拿大

第八章:亚太女性科技(Femtech)市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章:南美女性科技(Femtech)市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章:中东与非洲女性科技(Femtech)市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 南非
    • 阿联酋
    • 沙乌地阿拉伯

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 产品发布
  • 併购
  • 技术进步

第 13 章:波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品/服务的威胁

第 14 章:全球女性科技 (Femtech) 市场:SWOT 分析

第 15 章:竞争格局

  • ALYK, Inc.
  • Aytu BioScience, Inc.
  • Biowink GmbH
  • Flo Health, Inc.
  • Glow, Inc.
  • NaturalCycles Nordic AB
  • Ovia Health
  • Plackal Tech
  • The Flex Company
  • Thinx, Inc.

第 16 章:策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 14399

Global Female Technology (Femtech) Market was valued at USD 39.34 Billion in 2024 and is expected to reach USD 97.88 Billion by 2030 with a CAGR of 16.41% during the forecast period. The global market for Female Technology (Femtech) is experiencing significant growth, driven by the increasing digital literacy rates, internet connectivity, smartphone penetration, and digital healthcare infrastructure. Further, the growing availability of smart wearable devices such as fitness trackers, and smartwatches are anticipated to lift the growth of the Female Technology (Femtech) market. In addition, the increasing adoption of digital solutions in developed and developing countries combined with advancements in technologies is expected to fuel the growth of the market during the forecast period. FemTech (Female Technology) is a technology that improves the health and well-being of women. This term is frequently used to refer to programs, services, products, software, hardware, vitamins, supplements, telehealth, wearables, digital platforms, and consumer goods intended to enhance or support the health of women, including but not limited to those who identify as cisgender women and women from gender or sexual minorities.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 39.34 Billion
Market Size 2030USD 97.88 Billion
CAGR 2025-203016.41%
Fastest Growing SegmentPregnancy and Nursing Care
Largest MarketNorth America

Femtech companies are focused on developing technology products and services that cater to the unique healthcare and wellness needs of women. As awareness about the importance of women's health and well-being increases, so does the demand for Femtech products. Additionally, investors are increasingly interested in investing in Femtech companies due to the potential for significant returns. For instance, in 2020, Femtech companies received over $820 million in funding, according to PitchBook. Hence, rising investment opportunities in the market is anticipated to support the growth of the Female Technology (Femtech) market.

Key Market Drivers

Rising Prevalence of Women's Health Issues

The increasing incidence of women's health conditions is a major catalyst for the growth of the Femtech market. Conditions such as endometriosis, polycystic ovary syndrome (PCOS), and menopause-related complications are becoming more prevalent, necessitating specialized healthcare solutions. According to the World Health Organization (WHO), endometriosis affects approximately 190 million women globally, equating to about 10% of women of reproductive age. This growing burden has highlighted the inadequacies in traditional healthcare systems to address women's specific health needs effectively. Consequently, there is a surge in demand for Femtech solutions that offer personalized care, remote monitoring, and data-driven insights. These technologies empower women to manage their health proactively, leading to better outcomes and increased quality of life.

Governments and healthcare organizations are also recognizing the importance of addressing women's health issues. Initiatives aimed at increasing awareness, funding research, and integrating women's health into broader healthcare policies are gaining momentum. Such support not only validates the significance of Femtech but also provides a conducive environment for its growth and integration into mainstream healthcare.

Key Market Challenges

Gender Bias in Medical Research and Design

A significant challenge facing the Femtech industry is the persistent gender bias in medical research and product design. Historically, medical studies have predominantly focused on male subjects, leading to a lack of comprehensive understanding of female physiology and health conditions. This oversight results in the development of healthcare solutions that may not effectively address women's specific needs. In the context of Femtech, this bias manifests in products that are not adequately tested or tailored for women, potentially compromising their efficacy and safety. Furthermore, the underrepresentation of women in clinical trials and research studies perpetuates this cycle, hindering the advancement of evidence-based solutions in women's health.

Addressing this challenge requires a concerted effort to prioritize gender-inclusive research and development. This includes ensuring diverse representation in clinical studies, investing in research focused on women's health issues, and involving women in the design and testing of healthcare technologies. Governmental policies and funding initiatives that support such inclusive practices are essential to overcoming this barrier and fostering innovation in the Femtech sector.

Key Market Trends

Expansion of Fertility and Reproductive Health Solutions

The Femtech market is witnessing a significant trend towards the expansion of fertility and reproductive health solutions. With societal shifts leading to delayed childbearing and increased awareness of reproductive health, there is a growing demand for technologies that assist in fertility tracking, conception, and overall reproductive wellness. Innovations in this space include mobile applications that monitor ovulation cycles, wearable devices that track physiological indicators, and telemedicine platforms offering consultations with fertility specialists. These tools empower women with information and support, enabling informed decisions about their reproductive health.

Furthermore, the integration of artificial intelligence (AI) and machine learning into these solutions enhances their predictive capabilities, offering personalized recommendations and early detection of potential issues. This technological advancement not only improves user experience but also increases the efficacy of fertility treatments. Healthcare providers and policymakers are also recognizing the importance of reproductive health, leading to increased funding and supportive regulations. Such initiatives facilitate the development and accessibility of fertility-focused Femtech solutions, contributing to the overall growth of the market.

Key Market Players

  • ALYK, Inc.
  • Aytu BioScience, Inc.
  • Biowink GmbH
  • Flo Health, Inc.
  • Glow, Inc.
  • NaturalCycles Nordic AB
  • Ovia Health
  • Plackal Tech
  • The Flex Company
  • Thinx, Inc.

Report Scope:

In this report, the Global Female Technology (Femtech) Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Female Technology (Femtech) Market, By Product:

  • Mobile Apps
  • Connected Devices
  • Services
  • Others

Female Technology (Femtech) Market, By Application:

  • Reproductive Health
  • General Wellness
  • Pregnancy and Nursing Care
  • Pelvic and Uterine Care

Female Technology (Femtech) Market, By End-use:

  • Individuals
  • Fertility Clinics
  • Hospitals and Research Institutes
  • Diagnostic Centers

Female Technology (Femtech) Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Female Technology (Femtech) Market.

Available Customizations:

Global Female Technology (Femtech) Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Female Technology (Femtech) Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
    • 5.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
    • 5.2.3. By End-use (Individuals, Fertility Clinics, Hospitals, and Research Institutes, Diagnostic Centers)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Product Map
    • 5.3.1. By Product
    • 5.3.2. By Application
    • 5.3.3. By End-use
    • 5.3.4. By Region

6. Europe Female Technology (Femtech) Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
    • 6.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
    • 6.2.3. By End-use (Individuals, Fertility Clinics, Hospitals, and Research Institutes, Diagnostic Centers)
    • 6.2.4. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Female Technology (Femtech) Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-use
    • 6.3.2. United Kingdom Female Technology (Femtech) Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-use
    • 6.3.3. Italy Female Technology (Femtech) Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-use
    • 6.3.4. Germany Female Technology (Femtech) Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product
        • 6.3.4.2.2. By Application
        • 6.3.4.2.3. By End-use
    • 6.3.5. Spain Female Technology (Femtech) Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product
        • 6.3.5.2.2. By Application
        • 6.3.5.2.3. By End-use

7. North America Female Technology (Femtech) Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
    • 7.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
    • 7.2.3. By End-use (Individuals, Fertility Clinics, Hospitals and Research Institutes, Diagnostic Centers)
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Female Technology (Femtech) Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-use
    • 7.3.2. Mexico Female Technology (Femtech) Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-use
    • 7.3.3. Canada Female Technology (Femtech) Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-use

8. Asia-Pacific Female Technology (Femtech) Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
    • 8.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
    • 8.2.3. By End-use (Individuals, Fertility Clinics, Hospitals and Research Institutes, Diagnostic Centers)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Female Technology (Femtech) Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-use
    • 8.3.2. India Female Technology (Femtech) Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-use
    • 8.3.3. Japan Female Technology (Femtech) Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-use
    • 8.3.4. South Korea Female Technology (Femtech) Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-use
    • 8.3.5. Australia Female Technology (Femtech) Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-use

9. South America Female Technology (Femtech) Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
    • 9.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
    • 9.2.3. By End-use (Individuals, Fertility Clinics, Hospitals and Research Institutes, Diagnostic Centers)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Female Technology (Femtech) Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-use
    • 9.3.2. Argentina Female Technology (Femtech) Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-use
    • 9.3.3. Colombia Female Technology (Femtech) Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-use

10. Middle East and Africa Female Technology (Femtech) Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
    • 10.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
    • 10.2.3. By End-use (Individuals, Fertility Clinics, Hospitals and Research Institutes, Diagnostic Centers)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Female Technology (Femtech) Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-use
    • 10.3.2. UAE Female Technology (Femtech) Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-use
    • 10.3.3. Saudi Arabia Female Technology (Femtech) Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Product Launches
  • 12.2. Mergers & Acquisitions
  • 12.3. Technological Advancements

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products/Services

14. Global Female Technology (Femtech) Market: SWOT Analysis

15. Competitive Landscape

  • 15.1. ALYK, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Aytu BioScience, Inc.
  • 15.3. Biowink GmbH
  • 15.4. Flo Health, Inc.
  • 15.5. Glow, Inc.
  • 15.6. NaturalCycles Nordic AB
  • 15.7. Ovia Health
  • 15.8. Plackal Tech
  • 15.9. The Flex Company
  • 15.10. Thinx, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer